Pretransplant Kinetics of Anti-HLA Antibodies in Patients on the Waiting List for Kidney Transplantation

被引:10
|
作者
Togninalli, Matteo [1 ,2 ]
Yoneoka, Daisuke [1 ,2 ]
Kolios, Antonios G. A. [3 ]
Borgwardt, Karsten [1 ,2 ]
Nilsson, Jakob [3 ]
机构
[1] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Machine Learning & Computat Biol Lab, Zurich, Switzerland
[2] SIB, Lausanne, Switzerland
[3] Univ Hosp Zurich, Dept Immunol, Gloriastr 23, CH-8091 Zurich, Switzerland
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2019年 / 30卷 / 11期
关键词
anti-HLA antibodies; kidney transplantation; single antigen beads; donor specific antibodies; mean fluorescence intensity; SENSITIZATION; EVENTS;
D O I
10.1681/ASN.2019060594
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Patients on organ transplant waiting lists are evaluated for preexisting alloimmunity to minimize episodes of acute and chronic rejection by regularly monitoring for changes in alloimmune status. There are few studies on how alloimmunity changes over time in patients on kidney allograft waiting lists, and an apparent lack of research-based evidence supporting currently used monitoring intervals. Methods To investigate the dynamics of alloimmune responses directed at HLA antigens, we retrospectively evaluated data on anti-HLA antibodies measured by the single-antigen bead assay from 627 waitlisted patients who subsequently received a kidney transplant at University Hospital Zurich, Switzerland, between 2008 and 2017. Our analysis focused on a filtered dataset comprising 467 patients who had at least two assay measurements. Results Within the filtered dataset, we analyzed potential changes in mean fluorescence intensity values (reflecting bound anti-HLA antibodies) between consecutive measurements for individual patients in relation to the time interval between measurements. Using multiple approaches, we found no correlation between these two factors. However, when we stratified the dataset on the basis of documented previous immunizing events (transplant, pregnancy, or transfusion), we found significant differences in the magnitude of change in alloimmune status, especially among patients with a previous transplant versus patients without such a history. Further efforts to cluster patients according to statistical properties related to alloimmune status kinetics were unsuccessful, indicating considerable complexity in individual variability. Conclusions Alloimmune kinetics in patients on a kidney transplant waiting list do not appear to be related to the interval between measurements, but are instead associated with alloimmunization history. This suggests that an individualized strategy for alloimmune status monitoring may be preferable to currently used intervals.
引用
收藏
页码:2262 / 2274
页数:13
相关论文
共 50 条
  • [21] ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATION
    Ho, Eric K.
    Vlad, George
    Colovai, Adriana I.
    Vasilescu, Rodica
    Schwartz, Joseph
    Sondermeijer, Hugo
    Burke, Elizabeth
    Marboe, Charles C.
    Itescu, Silviu
    Suciu-Foca, Nicole
    Mancini, Donna M.
    HUMAN IMMUNOLOGY, 2009, 70 : S25 - S25
  • [22] Methodologies for anti-HLA antibodies screening in patients awaiting kidney transplantation: a comparative study
    Minucci, P. B.
    Grimaldi, V.
    Casamassimi, A.
    Cacciatore, F.
    Cascella, M. R.
    Conte, S.
    Crudele, V.
    Damiano, B.
    De Luca, F. P.
    De Ponte, A.
    Di Mauro, T.
    Esposito, V.
    Farzati, B.
    Ferriero, M. R.
    Infante, T.
    La Rocca, R.
    Mascolo, M.
    Panzanella, P.
    Parente, D.
    Picascia, A.
    Pignalosa, O.
    Resse, M.
    Russo, A.
    Siervo, A.
    Verazzo, C.
    Villano, A.
    Amodio, G.
    Ziello, F.
    Napoli, C.
    TISSUE ANTIGENS, 2011, 77 (05): : 470 - 470
  • [23] Anti-HLA antibodies in heart transplantation
    Suciu-Foca, N.
    Vasilescu, E. R.
    Colovai, A. I.
    Ho, E.
    Medinger, L.
    Deng, M.
    Cadeiras, M.
    Cortesini, R.
    Marboe, C.
    Itescu, S.
    Mancini, D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S154 - S154
  • [24] Anti-HLA antibodies in heart transplantation
    Vasilescu, ER
    Ho, EK
    de la Torre, L
    Itescu, S
    Marboe, C
    Cortesini, R
    Suciu-Foca, N
    Mancini, D
    TRANSPLANT IMMUNOLOGY, 2004, 12 (02) : 177 - 183
  • [25] EVALUATION OF PRA-CDC FOR ANTI-HLA CLASS II IN HYPERIMMUNE PATIENTS ON THE WAITING LIST FOR KIDNEY TRANSPLANT
    Mininni, Donata
    Margiotta, Marcella
    Trentadue, Anna
    Marzella, Rosalia
    Martino, Carmela
    Monteleone, Mario Vito
    Mongelli, Giovanna
    Morici, Roberta
    HLA, 2016, 87 (04) : 252 - 253
  • [26] Graft loss predictive value of anti-HLA antibodies in kidney transplantation
    Campos, EF
    Tedesco, H
    Pestana, JOM
    Park, SI
    Gerbase-DeLima, M
    GENES AND IMMUNITY, 2005, 6 : S8 - S8
  • [27] Clinical relevance of anti-HLA antibodies monitoring after kidney transplantation
    Souza, P. S.
    Panajotopoulos, N.
    David, D. S. R.
    Ronda, C.
    Agena, F.
    Rodrigues, H.
    Lanhez, L. E.
    David-Neto, E.
    Kalil, J. E.
    Castro, M. C. R.
    TISSUE ANTIGENS, 2008, 71 (04): : 288 - 288
  • [28] Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation
    Ishida, Hideki
    Hirai, Toshihito
    Kohei, Naoki
    Yamaguchi, Yutaka
    Tanabe, Kazunari
    TRANSPLANT INTERNATIONAL, 2011, 24 (02) : 150 - 157
  • [29] Impact of Preformed Anti-HLA Antibodies in the Outcomes of Kidney Transplantation.
    Santos, S.
    Malheiro, J.
    Costa, M.
    Campos, A.
    Pedroso, S.
    Almeida, M.
    Martins, L.
    Dias, L.
    Henriques, C.
    Cabrita, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 490 - 491
  • [30] Impact of COVID-19 on anti-HLA antibodies in kidney transplantation
    de Sousa, Marcos Vinicius
    Gomes, Bruno Teixeira
    Goncalez, Ana Claudia
    Mazzali, Marilda
    TRANSPLANT IMMUNOLOGY, 2024, 86